Fresenius Medical Care AG & Co. KGaA (FMS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$0.61
Street estimate
Revenue target
$5.71B
Street estimate
Trailing EPS (avg 4Q)
$0.67
Beat rate last 4: 75%
Latest EPS YoY
+26.9%
vs 2025-08-05
Latest revenue YoY
-0.7%
How results look so far
Trailing revenue (avg 4Q)
$5.67B
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS beat
EPS actual / est
$0.66 / $0.62
+7.1%
Revenue actual / est
$5.60B / $5.48B
+2.2%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $0.61 | Pending | — | $5.71B | Pending | — |
| 8/3/2026 | $0.62 | $0.66 | +7.1% | $5.48B | $5.60B | +2.2% |
| 5/5/2026 | $0.59 | $0.53 | -10.2% | $5.41B | $5.40B | -0.1% |
| 2/24/2026 | $0.65 | $0.83 | +28.3% | $5.67B | $5.97B | +5.3% |
| 11/4/2025 | $0.59 | $0.64 | +8.5% | $4.80B | $5.72B | +19.2% |
| 8/5/2025 | $0.50 | $0.52 | +4.0% | $4.98B | $5.64B | +13.4% |
| 5/6/2025 | $0.43 | $0.44 | +2.3% | $5.06B | $5.35B | +5.8% |
| 2/25/2025 | $0.41 | $0.48 | +17.1% | $4.66B | $5.27B | +13.1% |
| 11/5/2024 | $0.38 | $0.45 | +18.4% | $5.22B | $5.22B | -0.1% |
| 7/30/2024 | $0.38 | $0.38 | 0.0% | $5.30B | $5.13B | -3.3% |
| 5/7/2024 | $0.26 | $0.36 | +38.5% | $5.08B | $5.08B | -0.2% |
| 2/20/2024 | $0.36 | $0.47 | +30.6% | $5.36B | $5.49B | +2.3% |
| 11/1/2023 | $0.31 | $0.28 | -9.7% | $5.20B | $5.21B | +0.1% |
| 8/2/2023 | $0.24 | $0.32 | +33.3% | $5.30B | $5.26B | -0.7% |
| 5/9/2023 | $0.18 | $0.28 | +55.6% | $5.14B | $5.11B | -0.4% |
| 2/21/2023 | $0.22 | $0.44 | +100.0% | $5.30B | $5.38B | +1.5% |
| 10/30/2022 | $0.34 | $0.40 | +17.6% | $4.88B | $4.98B | +2.1% |
| 7/28/2022 | $0.43 | $0.39 | -9.3% | $4.77B | $4.98B | +4.3% |
| 5/4/2022 | $0.26 | $0.34 | +30.8% | $4.84B | $5.03B | +4.0% |
| 2/22/2022 | $0.43 | $0.45 | +4.7% | $5.22B | $5.27B | +0.9% |
| 11/2/2021 | $0.45 | $0.47 | +4.4% | $5.43B | $5.16B | -5.1% |
| 7/30/2021 | $0.47 | $0.38 | -19.1% | $4.32B | $5.13B | +18.6% |
| 5/6/2021 | $0.38 | $0.42 | +10.5% | — | $4.95B | — |
| 2/23/2021 | $0.70 | $0.76 | +8.6% | $4.40B | $5.40B | +22.6% |
| 10/29/2020 | $0.54 | $0.60 | +11.1% | $3.92B | $5.18B | +32.1% |
| 7/30/2020 | $0.53 | $0.60 | +13.2% | $3.96B | $5.13B | +29.6% |
| 5/6/2020 | $0.60 | $0.47 | -21.7% | $5.46B | $4.88B | -10.6% |
| 2/20/2020 | $0.63 | $0.68 | +7.9% | $4.22B | $5.20B | +23.2% |
| 10/29/2019 | $0.56 | $0.61 | +8.9% | $4.02B | $4.84B | +20.4% |
| 7/30/2019 | $0.49 | $0.46 | -6.1% | $4.61B | $4.93B | +7.0% |
| 5/2/2019 | $0.48 | $0.52 | +8.3% | $3.79B | $4.64B | +22.5% |
| 2/20/2019 | $0.61 | $0.67 | +9.8% | $3.88B | $5.14B | +32.5% |
| 10/30/2018 | $0.56 | $0.51 | -8.9% | $4.42B | $4.73B | +7.0% |
| 7/31/2018 | $0.60 | $0.54 | -10.0% | $4.70B | $4.89B | +4.1% |
| 5/3/2018 | $0.74 | $0.56 | -24.3% | $4.95B | $4.90B | -1.1% |
| 2/26/2018 | $0.70 | $0.68 | -2.9% | $4.43B | $5.20B | +17.3% |
| 11/2/2017 | $0.56 | $0.59 | +5.4% | $4.16B | $5.11B | +22.9% |
| 8/1/2017 | $0.54 | $0.48 | -11.1% | $4.77B | $5.10B | +6.8% |
| 5/3/2017 | $0.44 | $0.53 | +20.5% | $3.41B | $4.84B | +41.8% |
| 2/22/2017 | $0.62 | $0.64 | +3.2% | $5.15B | $4.67B | -9.3% |
| 10/27/2016 | $0.52 | $0.54 | +3.8% | $4.10B | $4.60B | +12.2% |